The STARS-Trial: To Assess Stent Apposition by Optical Coherence Tomography (OCT) of the Svelte Sirolimus-Eluting Coronary Stent Systems (IDS and RX) Compared to the Abbott Vascular Xience Everolimus-Eluting Coronary Stent System for the Treatment of Atherosclerotic Lesions in a Randomized Study

Phase 4

Completed

• Conditions: Coronary artery disease; atherosclerosis; 10011082

• Registration Number: NL-OMON55040
• Lead Sponsor: Amphia Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 250

Inclusion Criteria

- Subject has symptomatic coronary artery disease with objective evidence of
ischemia or silent ischemia

Exclusion Criteria

- Subject has cardiogenic shock, hemodynamic instability requiring inotropic or
mechanical circulatory support, intractable ventricular arrhythmia, or ongoing
intractable angina;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Stent appossition</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Stent expansion<br /><br>Edge dissection<br /><br>Total number of balloons used</p><br>